ELIZABETH SYMANSKI: Open Payments
NPI 1538471222 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 18 payments from 10 companies in 2025. Trend: 2023 $708 · 2024 $323 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| Gilead Sciences, Inc. | 1 | $126 |
| Phadia US Inc. | 1 | $94 |
| Hologic Sales and Service, LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| Lilly USA, LLC | 2 | $44 |
| ABIOMED | 1 | $27 |
| PFIZER INC. | 1 | $23 |
| ViiV Healthcare Company | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: BREZTRI, ImmunoCAP, APTIMA, SHINGRIX, MOUNJARO, AIRSUPRA, PAXLOVID, APRETUDE.
Industry payments across CA — which companies pay providers there.
